<DOC>
	<DOCNO>NCT01340677</DOCNO>
	<brief_summary>The purpose study evaluate effect dose pharmacokinetics canagliflozin healthy volunteer .</brief_summary>
	<brief_title>A Pharmacokinetic Dose Proportionality Study Canagliflozin Healthy Volunteers</brief_title>
	<detailed_description>This open-label study healthy volunteer know name dose assign treatment randomly assign take single oral ( mouth ) dose canagliflozin sequentially 3 treament period dose treatment period different ( referred 3-period crossover study ) evaluate pharmacokinetics ( blood level ) 3 dose level canagliflozin . Healthy volunteer take single oral tablet canagliflozin 50 mg ( Treatment A ) , 100 mg ( Treatment B ) , 300 mg ( Treatment C ) study ; different dose take treatment period . Study drug take a.m. Day 1 Treatment Periods 1 , 2 , 3 , 10- 14-day washout period Day 1 treatment period . Volunteers fast ( go without food ) least 10 hour least 4 hour take study drug .</detailed_description>
	<mesh_term>Canagliflozin</mesh_term>
	<criteria>Healthy volunteer body mass index 18 30 kg/m2 ( inclusive ) body weight less 50 kg History current medical illness deem clinically significant Investigator ( study physician )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Canagliflozin ( JNJ-28431754 )</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Dose proportionality</keyword>
</DOC>